Article

Diagnostics firm rejects Escalon stock offer

London-The board of Drew Scientific Group PLC, a diagnostics company specializing in the design, manufacture, sale, and distribution of analytical systems for laboratory testing, has rejected Escalon Medical Corp.'s offer to trade its stock for Drew shares.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) CCOI Myopia Workshop: Michael X. Repka, MD, MBA, on building consensus and future directions
(Image credit: Ophthalmology Times) Introducing iOpeners: Unpacking high-yield ophthalmology tips and clinical pearls, with Nicole Bajic, MD
© 2025 MJH Life Sciences

All rights reserved.